Overview:
This webinar will describe how a pharmaceutical company can prolong the life of a drug product. The high cost of time, money, and man-hours to develop a new pharmaceutical drug requires that the company hang onto the drug especially during the patent period. Examples will include new formulations, indications, and additional patient populations. Healthy pharmaceutical companies take pride in adding years to a drug’s patent process life. People who are responsible for this result are often promoted because of the positive effect on the company’s health.
Why Should You Attend:
Healthy pharmaceutical companies take pride in adding years to a pharmaceutical product’s life. People who are responsible for this result are often promoted because of the positive effect on the company’s health. As employees stay with the company and get older, there is often a fear that the company will not continue to keep a person employed especially as he/she gets closer to pension age. They need to get associated with a drug’s name and longevity.
Areas Covered in this Webinar:
Pharmaceutical companies have numerous areas that are associated with most drugs. In the business side marketing looks to prepare advertising to prescribers and potential patients. Pharmaceutical manufacturing areas develop a new formulation and their colleagues make the new product for millions of patients. Scientists working with animals obtain basic safety information for a particular population that does not have data in the past. Clinical scientists develop safety, pharmacokinetic, and efficacy data in man to form the core of the data needed to get approved. Regulatory colleagues interact with regulatory agencies and team members to prepare important documents.
Learning Objectives:
This webinar will describe how a pharmaceutical company can prolong the life of a drug product using:
• New formulations,
• Indications, and
• Additional patient populations
Who Will Benefit:
• Project Managers
• Formulation Development Professionals
• Preclinical Development Professionals
• Clinical Development Professionals
• Regulatory Compliance Professionals
Level:
Intermediate
This webinar will describe how a pharmaceutical company can prolong the life of a drug product. The high cost of time, money, and man-hours to develop a new pharmaceutical drug requires that the company hang onto the drug especially during the patent period. Examples will include new formulations, indications, and additional patient populations. Healthy pharmaceutical companies take pride in adding years to a drug’s patent process life. People who are responsible for this result are often promoted because of the positive effect on the company’s health.
Why Should You Attend:
Healthy pharmaceutical companies take pride in adding years to a pharmaceutical product’s life. People who are responsible for this result are often promoted because of the positive effect on the company’s health. As employees stay with the company and get older, there is often a fear that the company will not continue to keep a person employed especially as he/she gets closer to pension age. They need to get associated with a drug’s name and longevity.
Areas Covered in this Webinar:
Pharmaceutical companies have numerous areas that are associated with most drugs. In the business side marketing looks to prepare advertising to prescribers and potential patients. Pharmaceutical manufacturing areas develop a new formulation and their colleagues make the new product for millions of patients. Scientists working with animals obtain basic safety information for a particular population that does not have data in the past. Clinical scientists develop safety, pharmacokinetic, and efficacy data in man to form the core of the data needed to get approved. Regulatory colleagues interact with regulatory agencies and team members to prepare important documents.
Learning Objectives:
This webinar will describe how a pharmaceutical company can prolong the life of a drug product using:
• New formulations,
• Indications, and
• Additional patient populations
Who Will Benefit:
• Project Managers
• Formulation Development Professionals
• Preclinical Development Professionals
• Clinical Development Professionals
• Regulatory Compliance Professionals
Level:
Intermediate
